ZeaVaxx
ZEAVAXX LLC is an Indiana-based animal healthcare company dedicated to improving current animal vaccines through a plant-derived nanoparticle adjuvant platform. Their proprietary platform, Zea-11, is a glucan-based nanoparticle derived from plants, designed to enhance vaccine efficacy. Founded by experts from Purdue University, the company aims to revolutionize veterinary vaccines with innovative technology.
Industries
Nr. of Employees
small (1-50)
ZeaVaxx
Purdue Railyard, 1281 Win Hentschel Blvd., West Lafayette, IN 47906, USA
Products
Plant-derived glucan-based nanoparticle adjuvant
A glucan-based nanoparticle material extracted from plants and chemically functionalized for use as an adjuvant in animal vaccine formulations; positioned as a cost-feasible alternative to traditional aluminum-containing adjuvants.
Plant-derived glucan-based nanoparticle adjuvant
A glucan-based nanoparticle material extracted from plants and chemically functionalized for use as an adjuvant in animal vaccine formulations; positioned as a cost-feasible alternative to traditional aluminum-containing adjuvants.
Services
Licensing the plant-derived nanoparticle adjuvant platform to animal healthcare and vaccine companies for integration into vaccine product lines.
Development of proprietary animal vaccine candidates that incorporate the plant-derived nanoparticle adjuvant platform.
Licensing the plant-derived nanoparticle adjuvant platform to animal healthcare and vaccine companies for integration into vaccine product lines.
Development of proprietary animal vaccine candidates that incorporate the plant-derived nanoparticle adjuvant platform.
Expertise Areas
- Animal vaccine development
- Adjuvant development
- Nanoparticle formulation
- Vaccine formulation and compatibility
Key Technologies
- Plant-derived glucan nanoparticles
- Nanoparticle-based adjuvants
- Chemical functionalization of biomaterials
- Vaccine formulation methods
News & Updates
ZeaVaxx was awarded the 3rd place of the Gold Division.
ZeaVaxx was awarded the Black Award.
ZeaVaxx was named one of the finalists.
ZeaVaxx participated in the NSF I-Corps program.
ZeaVaxx will present at the Ag Tech Investor Conference 2017 in Des Moines, IA.
Zea-11 patent was granted by USPTO.
ZeaVaxx was awarded the 3rd place of the Gold Division.
ZeaVaxx was awarded the Black Award.
ZeaVaxx was named one of the finalists.
ZeaVaxx participated in the NSF I-Corps program.
ZeaVaxx will present at the Ag Tech Investor Conference 2017 in Des Moines, IA.
Zea-11 patent was granted by USPTO.